Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.51% is 81% below its 5-year average of 2.70%, near the low end of its 5-year range (0.51%–22.38%).
As of the fiscal period ended Tuesday, June 30, 2026. 90.73% below its 12-month average of 5.48%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.51%.
DEBT TO ASSETS RATIO
0.51%
DEBT TO ASSETS RATIO AVG TTM
5.48%
DEBT TO ASSETS RATIO AVG 3Y
2.62%
DEBT TO ASSETS RATIO AVG 5Y
2.70%
DEBT TO ASSETS RATIO AVG 10Y
2.43%
DEBT TO ASSETS RATIO AVG 15Y
1.72%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-90.73%
CURRENT VS 3Y AVG
-80.64%
CURRENT VS 5Y AVG
-81.20%
CURRENT VS 10Y AVG
-79.05%
CURRENT VS 15Y AVG
-70.42%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 536 covered companies
CURRENT VS SECTOR MEDIAN
+408.27%
vs the sector median at left
IceCure Medical Ltd
Market Cap
$3.38M
Debt to Assets Ratio
0.51%
TTM Avg
5.48%
3Y Avg
2.62%
5Y Avg
2.70%
Market Cap
$3.35M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.42M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.13M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.05M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IceCure Medical Ltd (ICCM) | $3.38M | 0.51% | 5.48% | 2.62% | 2.70% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.35M | 0.06% | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.41M | 0.16% | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | 0.00% | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | N/A | N/A | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.21M | 0.00% | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | 0.77% | N/A | N/A | N/A |
| Eocene Ltd. (EOCN)vs › | $3.67M | N/A | N/A | N/A | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.05M | 0.01% | N/A | N/A | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.84M | 0.49% | N/A | N/A | N/A |
Debt/Assets
0.5%
Debt/Equity
0.01
Current Ratio
2.87
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.51% |
| 2026-03-31 | 1.04% |
| 2025-12-31 | 1.56% |
| 2025-09-30 | 1.91% |
| 2025-06-30 | 22.38% |
| 2025-03-31 | 3.42% |
| 2024-12-31 | 3.65% |
| 2024-09-30 | 3.18% |
| 2024-06-30 | 3.39% |
| 2024-03-31 | 3.42% |
| 2023-12-31 | 3.65% |
| 2023-09-30 | 3.09% |
| 2023-06-30 | 2.67% |
| 2023-03-31 | 2.01% |
| 2022-12-31 | 1.98% |
| 2022-09-30 | 3.32% |
| 2022-06-30 | 3.09% |
| 2022-03-31 | 2.95% |
| 2021-12-31 | 2.82% |
| 2021-09-30 | 5.14% |
| 2021-06-30 | 1.26% |
| 2020-12-31 | 3.24% |
| 2020-06-30 | 4.10% |
| 2020-03-31 | 4.10% |
| 2019-12-31 | 3.35% |
| 2019-09-30 | 1.51% |
| 2019-06-30 | 6.56% |
| 2019-03-31 | 5.56% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 48.48% |
| 2017-09-30 | 35.48% |
| 2017-06-30 | 15.59% |
| 2017-03-31 | 15.59% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.06% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 1.44% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.22% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
